CannAssure Therapeutics

Developer and provider of medical cannabis products and pharmaceutical cannabinoid medicines.

Health Tech & Life Sciences
Acquired by Paragon Retail
Public Ashdod, Israel Founded 2016
Last updated 2026-07-26
Total raised
$5.6M
Stage
Public
Founded
2016
Headcount
25
HQ
Ashdod, Israel
Sector
Health Tech & Life Sciences

About

CannAssure Therapeutics is an Israeli company focused on the development and provision of high-quality medical cannabis products and pharmaceutical cannabinoid medicines. They operate a vertically integrated system, including indoor cultivation, extraction, processing, and R&D, aiming to ensure consistent and stable products. The company has also engaged in partnerships for the development of topical medical cannabis products.

Funding history · 2 rounds · $5.6M total

2020-07
Grant $235K
2018-12
Follow-on PO $5.4M
★ Solbar Food Technologies★ Direct Capital Investments Ltd.

Headcount over time

From 15 (2019-06) to 7 (2025-12) · -8 (-53%) · 13 points · source: Finder history + radar grounding
270 2019-06 2025-12

Q&A

What is CannAssure Therapeutics' primary business?
CannAssure Therapeutics is an Israeli company focused on the development and provision of high-quality medical cannabis products and pharmaceutical cannabinoid medicines. They operate a vertically integrated system including cultivation, extraction, processing, and R&D.
When was CannAssure Therapeutics acquired and by whom?
CannAssure Therapeutics was acquired by Paragon Retail in February 2023.
What is the current employee count for CannAssure Therapeutics?
CannAssure Therapeutics currently has 11-50 employees.
What was CannAssure Therapeutics' total funding raised?
CannAssure Therapeutics raised a total of $4,964,000.
When did CannAssure Therapeutics go public on the TASE?
CannAssure Therapeutics went public on the TASE in December 2018 through a reverse merger.
Did CannAssure Therapeutics receive any grants?
Yes, CannAssure Therapeutics received a grant of $235,000 in August 2020.
What was a significant partnership for CannAssure Therapeutics in December 2020?
In December 2020, CannAssure Therapeutics signed an exclusive distribution agreement with DanCann Pharma for Denmark, Norway, Sweden, and Finland.
Has CannAssure Therapeutics been granted any patents recently?
In August 2021, CannAssure Therapeutics was granted a patent by the Israel Patents Authority for an oral delivery method of cannabis and cannabinoid compositions.

Team · 2

Ran Amir
Founder · Founder
Nir Peles
Founder · Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B2CB2B

Highlights

1 Patents

Tags

pharmaceuticalsseedscannabismedical-productsmedical-cannabisdrug-deliverywomen-healthpatientsindoor-farmingtopical-treatmentdermatologyoral-drugsanti-inflammatory
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitecannassure.life/
LinkedInlinkedin.com/company/18300557
Facebookfacebook.com/Cannassure-1808292219297130
YouTubeyoutube.com/channel/UCXKUrgTKAeMkClylZKg9nJg
Instagraminstagram.com/cannassure

Identifiers & details

Legal nameCannassure Therapeutics Ltd.
Founded2016
Employees (exact)25
Market cap$60K
Status reasonPublic on TASE on Dec, 2018;

Acquisitions & public offerings

Acquired by Paragon Retail 2023-02

TypeDateExchangeTickerAmount
Reverse Merger2019-01TASECSURE

Radar intelligence

Web history (Wayback)

Domaincannassure.life

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515761138
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2017-12-24
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events0
Registered addressההדרים 2 אשדוד